Mizolastine

41 interactions 3 explained in plain English
Dr. Brian Staiger, PharmD, BCPS
Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Oxaliplatin Injection Metronidazole Injection Chloroquine Levofloxacin Metronidazole Topical Aripiprazole Injection
41 Major
All (41) Major (41)

Major

Mizolastine Sertraline Explained An increased risk of QT interval prolongation Details Mizolastine Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Mizolastine Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Mizolastine Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Mizolastine Arsenic Trioxide Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Mizolastine Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Mizolastine Arsenic Trioxide Injection Trisenox Increased risk of QT-interval prolongation and torsade de pointes Details Mizolastine Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Mizolastine Azithromycin AzaSite An increased risk of QT interval prolongation and torsade de pointes Details Mizolastine Anagrelide Agrylin Increased risk of QT interval prolongation Details Mizolastine Bedaquiline Sirturo Increased risk of QT interval prolongation Details Mizolastine Chloroquine Aralen® Increased risk of QT-interval prolongation Details Mizolastine Dasatinib Phyrago An increased risk of QT interval prolongation Details Mizolastine Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Mizolastine Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Mizolastine Dofetilide Tikosyn An increased risk of QT interval prolongation Details Mizolastine Encorafenib Braftovi Increased risk of QT interval prolongation Details Mizolastine Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Mizolastine Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details Mizolastine Fostemsavir Rukobia Increased risk of torsade de pointes Details Mizolastine Glasdegib Daurismo Increased risk of QT interval prolongation Details Mizolastine Goserelin Implant Zoladex Increased risk of QT interval prolongation Details Mizolastine Histrelin Implant Supprelin Increased risk of QT interval prolongation Details Mizolastine Hydroxychloroquine Plaquenil An increased risk of seizures and an increased risk of QT interval prolongation Details Mizolastine Inotuzumab Ozogamicin Injection Besponsa Increased risk of QT interval prolongation Details Mizolastine Ivabradine Corlanor Increased risk of QT prolongation Details Mizolastine Ketoconazole Topical Extina® Foam Increased risk of QT interval prolongation Details Mizolastine Lefamulin Xenleta Increased risk of QT interval prolongation Details Mizolastine Lenvatinib Lenvima Increased risk of QT-interval prolongation Details Mizolastine Levofloxacin Levaquin Increased risk of QT interval prolongation Details Mizolastine Levofloxacin Injection Levaquin Increased risk of QT interval prolongation Details Mizolastine Loperamide Diamode An increased risk of QT interval prolongation, which may increase risk of cardiotoxicity (torsade de pointes, cardiac arrest) Details Mizolastine Metronidazole Flagyl An increased risk of QT interval prolongation Details Mizolastine Metronidazole Injection Flagyl An increased risk of QT interval prolongation Details Mizolastine Metronidazole Topical MetroCream® An increased risk of QT interval prolongation Details Mizolastine Metronidazole Vaginal MetroGel® Vaginal An increased risk of QT interval prolongation Details Mizolastine Moxifloxacin Avelox Increased risk of QT interval prolongation Details Mizolastine Moxifloxacin Injection Avelox Increased risk of QT interval prolongation Details Mizolastine Moxifloxacin Ophthalmic Moxeza® Increased risk of QT interval prolongation Details Mizolastine Olodaterol Oral Inhalation Striverdi An increased risk of QT interval prolongation and an increased risk of ventricular arrhythmias Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist
Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.